Cannabix TechnologiesSTU:8CT +0.58%32 EV-to-FCF is -37.71 as of Jul. 08, 2026. GuruFocus rates STU:8CT with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 416 Medical Devices & Instruments companies, Cannabix Technologies ranks worse than 240384.38% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Cannabix Technologies's Enterprise Value is €44.08 Mil.
Cannabix Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 was €-1.17 Mil. Therefore, Cannabix Technologies's EV-to-FCF for today is -37.71.
The historical rank and industry rank for Cannabix Technologies's EV-to-FCF or its related term are showing as below:
STU:8CT'
s EV-to-FCF Range Over the Past 10 Years
Min: -49.21 Med: -35.83 Max: -28.92
Current: -36.8
During the past 13 years, the highest EV-to-FCF of Cannabix Technologies was -28.92. The lowest was -49.21. And the median was -35.83.
STU:8CT's EV-to-FCF is ranked worse than 100% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.515
vs STU:8CT: -36.80
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cannabix Technologies's PE Ratio (TTM) for today is calculated as:
Cannabix Technologies's share price for today is €0.344.
Cannabix Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.033.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Cannabix Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabix Technologies EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cannabix Technologies's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Cannabix Technologies's EV-to-FCF falls into.
Cannabix Technologies's current Enterprise Value is €44.08 Mil.
Cannabix Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.17 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabix Technologies (STU:8CT) has a EV-to-FCF of -37.71 as of Jul. 08, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cannabix Technologies and its competitors. According to the industry distribution chart, Cannabix Technologies ranks #999999 out of 416 companies in the Medical Devices & Instruments industry.
Is Cannabix Technologies' EV-to-FCF too high?
Cannabix Technologies' current EV-to-FCF is -37.71. Based on the distribution chart, Cannabix Technologies ranks #999999 out of 416 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cannabix Technologies has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Cannabix Technologies' EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cannabix Technologies ranks #999999 out of 416 companies for EV-to-FCF. This places Cannabix Technologies in the lower half of its industry. The industry median EV-to-FCF is 23.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.52, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cannabix Technologies and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabix Technologies's current EV-to-FCF is -37.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabix Technologies stock overvalued right now?
Cannabix Technologies (STU:8CT) has a current EV-to-FCF of -37.71. The current EV-to-FCF is -37.71. Cannabix Technologies' overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Cannabix Technologies (STU:8CT), the current EV-to-FCF is -37.71 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabix Technologies Inc is engaged in the development of marijuana and alcohol breath testing technologies. Its products are Cannabix Marijuana Breath Test and BreathLogix Alcohol Breathalyzer.
32GF Score
Get the complete analysis for STU:8CT
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:8CT has been successfully added to your 
